Bolibar I, Kienast J, Thompson S G, Matthias R, Niessner H, Fechtrup C
London School of Hygiene and Tropical Medicine, England.
Am Heart J. 1993 Jun;125(6):1601-5. doi: 10.1016/0002-8703(93)90747-w.
Six hundred fifty seven patients with angina pectoris underwent coronary angiography after measurement of plasma fibrinogen levels. Coronary artery disease (CAD) was angiographically confirmed in 75% of the patients. Other cardiac disease, either alone or in combination with CAD, was diagnosed in 8% and 11% of cases, respectively; 17% of the patients had no evidence of overt heart disease. Fibrinogen concentrations showed a graded increase according to the severity of coronary stenosis (p = 0.02) but were not significantly associated with any other cardiac heart disease. However, patients with valvular heart diseases had on average a 5.9% elevation of fibrinogen levels as compared to patients without proven cardiac disease (p = 0.08), similar to the observed 6.9% increase for CAD (p = 0.005). On average, patients with cardiomyopathies or pulmonary hypertension had only a 1.6% or 1.2% increase, respectively. The increase in fibrinogen levels associated with CAD was similar in patients with and without coexisting heart diseases. The results demonstrate a significant positive relation of fibrinogen to the presence and severity of CAD irrespective of a possible confounding influence from other cardiac diseases. The results therefore lend support to the hypothesis of a pathogenetic role for fibrinogen as a cardiovascular risk factor.
657例心绞痛患者在测定血浆纤维蛋白原水平后接受了冠状动脉造影。冠状动脉疾病(CAD)经血管造影证实见于75%的患者。单独或合并CAD诊断出其他心脏病的病例分别占8%和11%;17%的患者没有明显心脏病的证据。纤维蛋白原浓度根据冠状动脉狭窄的严重程度呈分级升高(p = 0.02),但与任何其他心脏病均无显著相关性。然而,与未证实有心脏病的患者相比,患有瓣膜性心脏病的患者纤维蛋白原水平平均升高5.9%(p = 0.08),与观察到的CAD患者6.9%的升高相似(p = 0.005)。平均而言,患有心肌病或肺动脉高压的患者分别仅升高1.6%或1.2%。CAD相关的纤维蛋白原水平升高在有或无并存心脏病的患者中相似。结果表明,无论其他心脏病可能产生的混杂影响如何,纤维蛋白原与CAD的存在及严重程度之间存在显著正相关。因此,这些结果支持了纤维蛋白原作为心血管危险因素具有致病作用的假说。